Evidence map›Paper›PMID 31871858›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2019

Transforming Endothelium with Platelet-Rich Plasma in Engineered Microvessels.

Ryan J Nagao, Raluca Marcu, Yuliang Wang, Lu Wang, Chris Arakawa, Cole DeForest, Junmei Chen, José A López, Ying Zheng

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Organ-on-a-chip systems for vascular biology.Journal of molecular and cellular cardiology · 2021
    Review
  9. Review
  10. Article
  11. Review
  12. Microfluidic Biomaterials.Advanced healthcare materials · 2021
    Review
  13. Article
  14. Transforming Endothelium with Platelet-Rich Plasma in Engineered Microvessels.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ryan J NagaoDepartment of Bioengineering University of Washington Seattle WA 98195 USA.
Raluca MarcuDepartment of Bioengineering University of Washington Seattle WA 98195 USA.
Yuliang WangDepartment of Computer Science and Engineering University of Washington Seattle WA 98195 USA.
Lu WangDepartment of Environmental and Occupational Health Sciences University of Washington Seattle WA 98105-6099 USA.
Chris ArakawaDepartment of Bioengineering University of Washington Seattle WA 98195 USA.
Cole DeForestDepartment of Bioengineering University of Washington Seattle WA 98195 USA.
Junmei ChenBloodworks Northwest Research Institute Seattle WA 98102 USA.
José A LópezDepartment of Chemical Engineering University of Washington Seattle WA 98195 USA.
Ying ZhengDepartment of Bioengineering University of Washington Seattle WA 98195 USA.ORCID https://orcid.org/0000-0003-2723-9022
University of Washington · USCalifornia Institute for Regenerative Medicine · USBloodworks Northwest · US

Funding

Tissue Chip Data to the Microphysiology Systems Database (MPS-Db) Supplement to A Microphysiological System for Kidney Disease Modeling and Drug Efficacy TestingUH3TR002158 · NCATS · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN · 2019 to 2021
$4.2M
Perfusable 3D human cardiac constructs for heart regenerationR01HL141570 · NHLBI · UNIVERSITY OF WASHINGTON · PI MURRY, CHARLES E, ZHENG, YING · 2018 to 2021
$3.3M
A Microphysiological System for Kidney Disease Modeling and Drug Efficacy TestingUG3TR002158 · NCATS · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN · 2017 to 2018
$2.9M
A Microfluidic Bone Marrow Niche for the Study of HematopoiesisDP2DK102258 · NIDDK · UNIVERSITY OF WASHINGTON · PI ZHENG, YING · 2013 to 2013
$2.6M
NCATS NIH HHS UG3 TR002158NCATS NIH HHS UH3 TR002158NHLBI NIH HHS R01 HL141570NIDDK NIH HHS DP2 DK102258
6 · The paper itself

Abstract

Vascularization remains an obstacle when engineering complex tissues for regeneration and disease modeling. Although progress has been made in recreating 3D vascular structures, challenges exist in generating a mature, functional endothelium. It is demonstrated that perfusing engineered microvessels with platelet-rich plasma, a critical homeostatic component in vivo that is often overlooked in vitro, substantially transforms the endothelium, both maturing endothelial cells and improving functionality in 24 h. Platelets readily adhered to the exposed collagen-I substrate through small gaps within engineered vessels without forming thrombi. The adherent platelets improve barrier function, enhance endothelial glycolysis, reduce thrombogenicity, and enrich smooth muscle cell growth surrounding the endothelium. These findings demonstrate that platelets are essential to the function of endothelium during vascular maturation and remodeling. This study sheds light on a potential strategy to engineer stable, implantable vascular networks.

Indexed as

endotheliumengineered microvesselspermeabilityplateletsPRP

Identifiers

PMID31871858
PMCPMC6918119
OpenAlexW2980349682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.